Itzler, R., Koch, G., Matson, D. O., Gothefors, L., Van Damme, P., DiNubile, M. J., & Heaton, P. M. (2010). Robustness of the healthcare utilization results from the Rotavirus Efficacy and Safety Trial (REST) evaluating the human-bovine (WC3) reassortant pentavalent rotavirus vaccine (RV5). BioMed Central.
Stile di citazione ChicagoItzler, Robbin, Gary Koch, David O. Matson, Leif Gothefors, Pierre Van Damme, Mark J. DiNubile, e Penny M. Heaton. Robustness of the Healthcare Utilization Results From the Rotavirus Efficacy and Safety Trial (REST) Evaluating the Human-bovine (WC3) Reassortant Pentavalent Rotavirus Vaccine (RV5). BioMed Central, 2010.
Citazione MLAItzler, Robbin, et al. Robustness of the Healthcare Utilization Results From the Rotavirus Efficacy and Safety Trial (REST) Evaluating the Human-bovine (WC3) Reassortant Pentavalent Rotavirus Vaccine (RV5). BioMed Central, 2010.